Related Experiment Videos
Complications of percutaneous therapy
1Department of Medical Imaging, The Middlesex Hospital, Mortimer Street, London, W1T 3AA, UK. a.gillams@medphys.ucl.ac.uk
Summary
Percutaneous tumour ablation is a safe, minimally invasive treatment with low complication rates, suitable for patients unable to undergo surgery. Common risks include bleeding or infection, but serious adverse events are rare.
Area of Science:
- Interventional Radiology
- Oncology
- Minimally Invasive Surgery
Background:
- Percutaneous tumour ablation is a minimally invasive, image-guided procedure.
- It offers a low morbidity rate (2%-10%) and exceptional procedure-related deaths.
- This technique is an alternative for patients unsuitable for surgical resection.
Purpose of the Study:
- To review the safety and efficacy of percutaneous tumour ablation.
- To categorize potential complications associated with the procedure.
- To highlight current and emerging applications of tumour ablation.
Main Methods:
- Review of existing literature on percutaneous tumour ablation.
- Analysis of complication data, categorized by type and location.
- Discussion of experience with radiofrequency ablation, particularly in liver cancer.
Main Results:
- Percutaneous tumour ablation demonstrates low morbidity and mortality.
- Complications are typically local (hemorrhage, infection, collateral damage) or systemic.
- Tumour dissemination is a rare occurrence despite being a theoretical risk.
Conclusions:
- Percutaneous tumour ablation is a safe and effective treatment option.
- Careful consideration of anatomical site and tumour type is necessary for complication management.
- Expanding applications in lung and renal cancers show promise for this minimally invasive approach.